You are here:
Home
Books
Books in English
Economics and Law
Finance and Investments
Pharmanomics. How Big Pharma Threatens Global Health
Pharmanomics. How Big Pharma Threatens Global Health
Author
Nick Dearden
Delivery 7 workdays
Club price:
24,95 €
Price:
24,95 €
-0%
Availability in stores
Share
How Big Pharma failed to end a pandemic, and what it tells us about the global economy
In Pharmanomics, investigative journalist Nick Dearden digs down into the way we produce our medicines and finds that Big Pharma is failing us, with catastrophic consequences.
Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financialising medicine – from Purdue´s rapacious marketing of highly addictive OxyContin through Martin Shkreli´s hiking the price of a lifesaving drug to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication.
Since the 1990s, Big Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response, Dearden offers a pathway to a fairer, safer system for all.
In Pharmanomics, investigative journalist Nick Dearden digs down into the way we produce our medicines and finds that Big Pharma is failing us, with catastrophic consequences.
Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financialising medicine – from Purdue´s rapacious marketing of highly addictive OxyContin through Martin Shkreli´s hiking the price of a lifesaving drug to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication.
Since the 1990s, Big Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response, Dearden offers a pathway to a fairer, safer system for all.
Delivery 7 workdays
Club price:
24,95 €
Price:
24,95 €
-0%
Availability in stores
Share
Format
Hardcover
Author
Nick Dearden
Language
English
Publishing company
Verso
Added date
29.11.2023
Year of publication
2023
Pages
336
Size
242 x 161 x 27 mm
Product code
9781804291450
Barcode
9781804291450
ISBN
9781804291450